Compounds > atorvastatin
Page last updated: 2024-08-24

atorvastatin and Graft-Versus-Host Disease

atorvastatin has been researched along with Graft-Versus-Host Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, KW; Atallah, E; Boyd, J; Bunner, P; Carlson, KS; Craig, M; Cumpston, A; D'Souza, A; Drobyski, W; Fenske, TS; Guru Murthy, GS; Hamadani, M; Hari, PN; Horowitz, MM; Kanate, AS; Michaelis, L; Pasquini, MC; Rizzo, JD; Saber, W; Visotcky, A1
Brundage, KM; Bunner, P; Craig, MD; Cumpston, A; Gibson, LF; Hamadani, M; Petros, W; Remick, SC; Tse, W; Vos, JA; Wen, S1
Andritsos, L; Benson, DM; Bingman, A; Blum, W; Bradbury, H; Chen, X; Coombes, K; Cortright, K; Daneault, B; Devine, SM; Efebera, YA; Elder, P; Garman, S; Garzon, R; Geyer, S; Hofmeister, CC; Hofstetter, J; Jaglowski, S; Kitzler, R; Klisovic, R; Lozanski, G; O'Donnell, L; Penza, S; Ranganathan, P; Scrape, SR; Vasu, S; Yu, J; Yu, X; Zhang, J1
Baker, J; Kambham, N; Negrin, RS; Steinman, L; Youssef, S; Zeiser, R1

Trials

3 trial(s) available for atorvastatin and Graft-Versus-Host Disease

ArticleYear
Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017, Volume: 23, Issue:8

    Topics: Adult; Aged; Allografts; Atorvastatin; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Male; Methotrexate; Middle Aged; Prospective Studies; Survival Rate; Tacrolimus

2017
Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Dec-10, Volume: 31, Issue:35

    Topics: Administration, Oral; Adult; Aged; Atorvastatin; Bacterial Infections; Cytokines; Feasibility Studies; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Siblings; Survival Analysis; Tissue Donors; Transplantation Immunology; Transplantation, Homologous; Treatment Outcome; Virus Diseases; Young Adult

2013
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:1

    Topics: Acute Disease; Adult; Aged; Allografts; Atorvastatin; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Middle Aged; Survival Rate; Tissue Donors

2016

Other Studies

1 other study(ies) available for atorvastatin and Graft-Versus-Host Disease

ArticleYear
Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity.
    Blood, 2007, Dec-15, Volume: 110, Issue:13

    Topics: Adoptive Transfer; Animals; Antigen Presentation; Atorvastatin; Chemoprevention; Cytokines; Graft vs Host Disease; Graft vs Leukemia Effect; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Mice, Knockout; Premedication; Pyrroles; Signal Transduction; STAT6 Transcription Factor; T-Lymphocytes; Th2 Cells

2007